Radioactive iodine therapy for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology, Pathology, Biology, Endocrine Surgery and Head and Neck Surgery

S. Zerdoud, S. Leboulleux, J. Clerc, L. Leenhardt, C. Bournaud, A. Al Ghuzlan, I. Keller, S. Bardet, A. L. Giraudet, L. Groussin, F. Sebag, R. Garrel, P. J. Lamy, M. E. Toubert, Mirallié, E. Hindié, D. Taïeb

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)
    Translated title of the contributionTraitement par iode 131 des cancers thyroïdiens différenciés: recommandations 2017 des sociétés françaises SFMN/SFE/SFP/SFBC/AFCE/SFORL
    Original languageEnglish
    Pages (from-to)S1-S22
    JournalMedecine Nucleaire
    Volume41
    DOIs
    Publication statusPublished - 1 Nov 2017

    Cite this